Modified fibrin hydrogel matrices: both, 3D-scaffolds and local and controlled release systems to stimulate angiogenesis.
about
A phage-targeting strategy for the design of spatiotemporal drug delivery from grafted matricesBladder acellular matrix conjugated with basic fibroblast growth factor for bladder regenerationCharacterization of the chemotactic and mitogenic response of SMCs to PDGF-BB and FGF-2 in fibrin hydrogelsA novel composite construct increases the vascularization potential of PEG hydrogels through the incorporation of large fibrin ribbons.Differential regulation of angiogenesis using degradable VEGF-binding microspheres.Designing degradable hydrogels for orthogonal control of cell microenvironments.Drug delivery strategies for therapeutic angiogenesis and antiangiogenesis.Biomaterials to prevascularize engineered tissues.Fibrin as a scaffold for cardiac tissue engineering.Experimental approaches to vascularisation within tissue engineering constructs.Platelet-rich plasma, a source of autologous growth factors and biomimetic scaffold for peripheral nerve regeneration.Platelet-rich plasma, an adjuvant biological therapy to assist peripheral nerve repair.Platelet-rich plasma gel in combination with Schwann cells for repair of sciatic nerve injuryRole of hyaluronan in angiogenesis and its utility to angiogenic tissue engineering.Enhanced angiogenic efficacy through controlled and sustained delivery of FGF-2 and G-CSF from fibrin hydrogels containing ionic-albumin microspheres.A novel poly(amido amine)-dendrimer-based hydrogel as a mimic for the extracellular matrix.3D Nanoprinting Technologies for Tissue Engineering Applications
P2860
Q33823155-3D96F1CB-D3C5-4091-B3B2-208EACB09CF0Q34063602-EF22B332-C5F9-4E85-BF7C-13F4D3E9F496Q34083818-424454BA-5D4D-4510-934D-25D7F030907FQ34086551-96F42418-7C65-4EBE-94AD-A77094750F38Q36899777-0F6A4601-C42D-4B19-A819-750C4FD782F6Q37146704-29207A76-BE8A-4D87-8046-EDAF02E9692CQ37845396-6128D054-6525-4E19-A7DA-8ABC10EF8546Q37926556-5D32DEAF-B25C-4E93-9290-4A3149E85ABEQ37945291-5A245040-997A-4733-811E-690606C29906Q38520494-D14BF332-68C5-4D0F-9E5B-CAC531870AB7Q39009135-4DEE360C-F7C4-47F0-9DC0-F803AF11FCF3Q39157166-238111BD-AF43-4D87-9957-4C0B8E28C769Q42126382-AAF9236A-E194-44FC-A1AE-D10E9012B532Q43189555-4D772706-2975-4885-BC0B-AFCC856B2D4FQ44673173-781C6400-B31B-4225-B62C-EC9AAC4C9768Q53575296-1D2C5DE4-CCB5-463D-BE18-A5DA690917DEQ59113213-6619713C-30C8-4194-B07E-4AD26C627409
P2860
Modified fibrin hydrogel matrices: both, 3D-scaffolds and local and controlled release systems to stimulate angiogenesis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Modified fibrin hydrogel matri ...... ems to stimulate angiogenesis.
@en
Modified fibrin hydrogel matri ...... ems to stimulate angiogenesis.
@nl
type
label
Modified fibrin hydrogel matri ...... ems to stimulate angiogenesis.
@en
Modified fibrin hydrogel matri ...... ems to stimulate angiogenesis.
@nl
prefLabel
Modified fibrin hydrogel matri ...... ems to stimulate angiogenesis.
@en
Modified fibrin hydrogel matri ...... ems to stimulate angiogenesis.
@nl
P1476
Modified fibrin hydrogel matri ...... ems to stimulate angiogenesis.
@en
P2093
Heike Hall
P304
P356
10.2174/138161207782794158
P577
2007-01-01T00:00:00Z